Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
The British Journal of Psychiatry. Supplement
|
April 1, 1994
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance
F A Wiesel
Neuroscience Letters
|
July 17, 2009
Effects of high dose propranolol treatment on dopamine and norepinephrine metabolism in regions of rat brain
F A Wiesel
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1992
Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment
F A Wiesel
Psychiatric Developments
|
January 1, 1989
Positron emission tomography in psychiatry
F A Wiesel
Journal of Neural Transmission. Supplementum
|
January 1, 1992
Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?
F A Wiesel
Psychiatry Research
|
October 1, 1991
Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia
G Wik, F A Wiesel
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1996
Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia
F A Wiesel, L Bjerkenstedt
Psychopharmacology
|
January 1, 1989
Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment
G Alfredsson, F A Wiesel
European Journal of Pharmacology
|
December 1, 1976
The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism
F A Wiesel, G Alfredsson
Psychopharmacology
|
January 1, 1990
Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients
G Alfredsson, F A Wiesel
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
The British Journal of Psychiatry. Supplement
|
April 1, 1994
Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance
F A Wiesel
Neuroscience Letters
|
July 17, 2009
Effects of high dose propranolol treatment on dopamine and norepinephrine metabolism in regions of rat brain
F A Wiesel
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1992
Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment
F A Wiesel
Psychiatric Developments
|
January 1, 1989
Positron emission tomography in psychiatry
F A Wiesel
Journal of Neural Transmission. Supplementum
|
January 1, 1992
Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?
F A Wiesel
Psychiatry Research
|
October 1, 1991
Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia
G Wik, F A Wiesel
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1996
Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia
F A Wiesel, L Bjerkenstedt
Psychopharmacology
|
January 1, 1989
Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment
G Alfredsson, F A Wiesel
European Journal of Pharmacology
|
December 1, 1976
The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism
F A Wiesel, G Alfredsson
Psychopharmacology
|
January 1, 1990
Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients
G Alfredsson, F A Wiesel
Page
of 9